Cellectar biosciences, inc. (CLRB)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-14,092

-13,239

-13,562

-6,180

-5,495

-8,052

-10,782

-8,796

-7,435

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

132

82

1,546

356

362

367

424

497

584

Stock-based compensation expense

866

721

758

529

447

850

2,323

1,503

907

Non cash lease Expense

56

0

-

-

-

-

-

-

-

Impairment of goodwill

0

1,675

0

-

-

-

-

-

-

Non-cash interest expense related to convertible debt

-

-

-

-

-

426

0

-

-

Intrinsic value of beneficial conversion feature associated with convertible debt

-

-

-

-

-

-

-

0

-257

Issuance of stock for technology and services

-

-

-

-

-

-

-

0

0

Impairment of intangible assets

-

-

-

-

-

-

-

0

0

Loss on disposal of fixed assets

-

-

-

-

-1

-2

-7

0

-6

Loss on revaluation of derivative warrants

43

62

22

3,261

3,667

2,285

2,373

-33

-

Gain on disposal of assets

0

50

0

-

-

-

-

-

-

(Gain) loss on revaluation of derivative warrants

-

-

-

-

-

-

-

-

-12

Loss on issuance of derivative warrants

-

-

-

-

-404

0

-744

0

-

Changes in:
Prepaid expenses and other current assets

129

229

-281

464

8

-74

-48

72

175

Other assets

-477

81

473

-

-

-

-

-

-

Lease liability

-81

0

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

1,120

-258

451

740

-258

-228

445

238

-294

Accrued interest

-

-

-

-

-

-

-

0

158

Deferred rent

-

-

-

-2

1

4

7

11

9

Cash used in operating activities

-

-

-

-

-8,212

-8,840

-9,154

-6,585

-

Cash used in operating activities

-11,693

-11,442

-11,020

-8,282

-

-

-

-

-5,970

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash acquired in a business combination

-

-

-

-

-

-

-

0

905

Purchases of fixed assets

24

384

346

72

58

29

147

97

118

Proceeds from sale of fixed assets

0

55

0

-

-

-

-

0

0

Purchases of short-term certificates of deposit

-

-

-

-

-

-

-

0

0

Proceeds from short-term certificates of deposit

-

-

-

-

-

-

-

0

0

Change in restricted cash

-

-

-

-

-

-

-2,000

2,000

-500

Payment for intangible assets

-

-

-

-

-

-

-

0

0

Cash used in investing activities

-

-

-

-

-58

-29

1,852

-2,097

-

Cash used in investing activities

-24

-329

-346

-72

-

-

-

-

1,287

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease obligations.

2

3

-

-

-

-

-

-

-

Cash paid for issuance costs

-

-

-

326

432

518

0

-

-

Proceeds from issuance of warrants

-

-

-

652

0

-

-

-

-

Reverse stock split fractional shares

0

-0

0

0

0

1

0

-

-

Proceeds from issuance of convertible notes

-

-

-

-

-

4,000

0

0

0

Proceeds from issuance of notes payable

-

-

-

-

-

617

0

-

-

Payments on notes payable

-

-

-

-

-

617

0

-

-

Proceeds from issuance of common stock, net of underwriting issuance costs

9,024

9,075

4,905

12,363

3,300

12,395

4,975

6,838

10,164

Payments on capital lease obligations

-

-

2

2

2

1

2

2

2

Proceeds from issuance of preferred stock

0

5,949

2,265

3,460

0

-

-

-

-

Change in deferred issuance costs

-

-

-116

38

-38

0

-

-

-

Proceeds from conversion of warrants

-

-

2,963

-

-

-

-

1,088

0

Proceeds from long-term obligations

-

-

-

-

-

-

-

0

0

Payments on long-term obligations

-

-

86

243

119

0

-

0

675

Repurchase of common stock

-

-

-

-

-

-

-

0

0

Cash in lieu of fractional shares in a business combination

-

-

-

-

-

-

-

0

0

Change in deferred issuance costs

-

-

-

-

-

-

70

-70

28

Cash provided by financing activities

-

-

-

-

2,706

15,874

5,043

7,854

-

Cash (used in) provided by financing activities

9,022

15,021

9,928

15,941

-

-

-

-

9,515

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-2,695

3,249

-1,438

-

-

-

-

-

-

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

7,586

-5,564

7,004

-2,259

-828

4,832

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest expense

0

0

0

4

-

-

-

-

-

Exchange of debentures and accrued interest for common stock

-

-

-

-

-

4,172

0

-

-

Fair value of derivative warrants issued

-

-

-

-

3,272

4,102

5,720

0

-

Relative fair value of warrants issued with debentures

-

-

-

-

-

254

0

-

-

Asset acquired by the issuance of a capital lease

-

-

-

-

-

13

0

-

-

Cash paid for interest expense

-

-

-

-

45

3

0

0

13

Fair value of derivative warrants reclassified to equity upon cashless exercise

-

-

-

-

-

-

-

43

48

Issuance of common stock in connection with the conversion of notes payable and $463,722 in accrued interest

-

-

-

-

-

-

-

0

3,184

Fair value of assets acquired in exchange for securities in a business combination

-

-

-

-

-

-

-

0

78

Reclassification to equity for warrants that are no longer derivative instruments

-

-

-

1,392

0

-

-

0

-439

Beneficial conversion feature and related deemed dividend on preferred stock

0

2,241

1,448

3,179

-

-

-

-

-

Conversion of preferred stock to common stock

1,377

4,419

-

-

-

-

-

-

-

Goodwill resulting from business combination

-

-

-

-

-

-

-

0

1,675